Assignee
ACEA THERAPEUTICS INC
US·7 granted patents·2 pending applications·6 citations·filing 2016–2024
Top patents by PatentIndex Score
9 records- 0188US11007197B2EGFR modulators and uses thereofACEA THERAPEUTICS INC·Filed 2019·Granted May 18, 2021·2 cites·18 claims
- 0276US10533011B2Pharmaceutical salts, physical forms, and compositions of pyrrolopyrimidine kinase inhibitors, and methods of making sameACEA THERAPEUTICS INC·Filed 2016·Granted Jan 14, 2020·4 cites·25 claims
- 0375US11987554B2Protease inhibitors as antiviralsACEA THERAPEUTICS INC·Filed 2023·Granted May 21, 2024·0 cites·16 claims
- 0474US2025122153A1Protease Inhibitors as AntiviralsACEA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0571US11753373B2Protease inhibitors as antiviralsACEA THERAPEUTICS INC·Filed 2022·Granted Sep 12, 2023·0 cites·18 claims
- 0667US11612602B2Heterocyclic compounds and uses as anticancer agentsACEA THERAPEUTICS INC·Filed 2020·Granted Mar 28, 2023·0 cites·20 claims
- 0756US2025136576A1Heterocyclic Compounds and Uses ThereofACEA THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0847US12358895B2Process for manufacture of (S)-N-(3-((2-((4-((1-acetylpyrrolidin-3-yl)(methyl)amino)phenyl)amino)-5-methoxypyrimidin-4-yl)oxy)phenyl)acrylamide, and formulations thereofACEA THERAPEUTICS INC·Filed 2018·Granted Jul 15, 2025·0 cites·18 claims
- 0941US11498922B2Pharmaceutical composition comprising N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1-yl phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenylacrylamideACEA THERAPEUTICS INC·Filed 2017·Granted Nov 15, 2022·0 cites·16 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →